Weight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program
Globe Newswire (Tue, 30-Jun 8:00 AM ET)
Weight Watchers to Support the American Heart Association's Healthy Living BEYOND Weight Study
Globe Newswire (Mon, 22-Jun 9:21 AM ET)
Globe Newswire (Tue, 16-Jun 4:01 PM ET)
Globe Newswire (Thu, 4-Jun 8:00 AM ET)
Clinical Subscriber Growth and High Gross Margins Highlight WW’s Q1 2026 Performance
Market Chameleon (Thu, 7-May 5:43 AM ET)
Weight Watchers Announces First Quarter 2026 Results
Globe Newswire (Thu, 7-May 7:00 AM ET)
Weight Watchers Expands Med+ With Access to New Ozempic pill (semaglutide)
Globe Newswire (Fri, 1-May 8:05 AM ET)
Weight Watchers Announces Actions to Utilize Up to $40 million to Pay Down Debt
Globe Newswire (Mon, 27-Apr 7:30 AM ET)
Weight Watchers Schedules First Quarter 2026 Earnings Conference Call
Globe Newswire (Thu, 23-Apr 4:01 PM ET)
Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors
Globe Newswire (Mon, 20-Apr 7:30 AM ET)
WW International Inc specializes in weight management and providing clinical solutions in the United States. it also operates its proprietary digital platform that provides members with access to science-backed behavioral weight loss and weight management programs. The company's primary sources of revenue are subscriptions for digital, workshop, and clinical offerings. The Digital business refers to providing subscriptions to digital product offerings. Workshops + Digital business provides subscriptions for unlimited access to workshops combined with digital subscription product offerings. The Clinical business provides subscriptions to clinical product offerings combined with digital subscription product offerings and unlimited access to workshops.
WW International trades on the NASDAQ stock market under the symbol WW.
As of July 7, 2026, WW stock price declined to $16.17 with 15,453 million shares trading.
WW has a beta of 1.37, meaning it tends to be more sensitive to market movements. WW has a correlation of 0.04 to the broad based SPY ETF.
WW has a market cap of $161.49 million. This is considered a Micro Cap stock.
Last quarter WW International reported $168 million in Revenue and -$5.20 earnings per share. This beat revenue expectation by $9 million and missed earnings estimates by -$3.13.
The top ETF exchange traded funds that WW belongs to (by Net Assets): VXF, FNDA, IWC, PRFZ, EES.
WW support price is $15.30 and resistance is $17.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that WW shares will trade within this expected range on the day.